{{Rsnum
|rsid=290489
|Gene=TCF7L2
|Chromosome=10
|position=114907055
|Orientation=plus
|GMAF=0.3655
|Gene_s=TCF7L2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.3 | 35.4 | 5.3
| HCB | 12.4 | 39.4 | 48.2
| JPT | 10.6 | 43.4 | 46.0
| YRI | 53.1 | 40.1 | 6.8
| ASW | 49.1 | 45.6 | 5.3
| CHB | 12.4 | 39.4 | 48.2
| CHD | 10.1 | 41.3 | 48.6
| GIH | 36.6 | 49.5 | 13.9
| LWK | 54.1 | 38.5 | 7.3
| MEX | 55.2 | 41.4 | 3.4
| MKK | 24.4 | 53.8 | 21.8
| TSI | 48.0 | 45.1 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23558246
|Title=Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients
}}

{{PMID Auto
|PMID=19351735
|Title=Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}